Nearly half (45%) of head and neck cancer clinical trials registered from 2005 to 2021 were never published. Trials without statistically significant results and those that were considered incomplete ...
Evaluation of p53 and BCL2 expression, mutation, and aneuploidy status on treatment response in an Indian cohort of primary Ca larynx No significant financial relationships to disclose. This is an ...